Edition:
United Kingdom

Sartorius Stedim Biotech SA (STDM.PA)

STDM.PA on Paris Stock Exchange

93.85EUR
11:28am BST
Change (% chg)

€0.10 (+0.11%)
Prev Close
€93.75
Open
€94.20
Day's High
€95.25
Day's Low
€93.85
Volume
12,798
Avg. Vol
53,102
52-wk High
€95.75
52-wk Low
€50.13

Select another date:

Tue, Apr 24 2018

BRIEF-Sartorius Stedim Biotech Net Profit Up at 47.1 Million Euros

* IN Q1 INCREASED ITS SALES REVENUE IN CONSTANT CURRENCIES BY 9.8% (REPORTED 4.6%) TO 281.1 MILLION EUROS.

BRIEF-Sartorius Stedim Biotech And Penn State University Entered Into Collaborative Partnership

* SARTORIUS STEDIM BIOTECH AND PENN STATE UNIVERSITY ENTERED INTO COLLABORATIVE PARTNERSHIP TO ADVANCE MULTIDISCIPLINARY TEACHING AND RESEARCH IN BIOTECHNOLOGY Source text : https://bit.ly/2qygOm0 Further company coverage: (Gdynia Newsroom)

BRIEF-Sartorius Stedim Biotech Launches New Ambr 250 High Throughput Bioreactor System

* LAUNCHES NEW AMBR 250 HIGH THROUGHPUT BIOREACTOR SYSTEM FOR PERFUSION CULTURE Source text: http://bit.ly/2FKA8C8 Further company coverage: (Gdynia Newsroom:)

BRIEF-Sartorius Stedim Biotech 2017 Underlying EBITDA Up By 2.2%

* SARTORIUS STEDIM BIOTECH TARGETS CONTINUED PROFITABLE GROWTH - SALES REVENUE PROJECTED AT AROUND 2.8 BILLION EUROS IN 2025

BRIEF-Sartorius Stedim Biotech Proposes Dividend For Fiscal 2017 Of 0.46 Euro Per Share

* ‍UNDER THIS PROPOSAL, TOTAL PROFIT DISTRIBUTED WOULD RISE BY 9.5% FROM EUR 38.7 MILLION TO EUR 42.4 MILLION.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

BRIEF-Sartorius Stedim Biotech FY EBITDA Up At ‍​294.9 Million Euros

* FY EBITDA EUR ‍​294.9 MILLION VERSUS EUR 288.7 MILLION YEAR AGO

Select another date: